H.R. 1076 would require the Government Accountability Office (GAO) to study the illicit financing of synthetic-drug trafficking and the federal government’s efforts to combat those activities. The bill would require the GAO to report its findings to the Congress within one year of enactment.
Based on the cost to produce similar reports, CBO estimates that implementing H.R. 1076 would cost less than $500,000 over the 2023-2028 period; any such spending would be subject to the availability of appropriated funds.
